ArticleTherapeutic advances in musculoskeletal disease2021

Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network.

Carla Gaggiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.